Autonomix Medical Common Stock Net Income
| AMIX Stock | 0.43 0.04 8.51% |
As of the 26th of January, Autonomix Medical shows the Risk Adjusted Performance of (0.07), standard deviation of 9.15, and Mean Deviation of 5.06. Autonomix Medical Common technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Autonomix Medical's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Autonomix Medical's valuation are provided below:We have found ninety-six available fundamental signals for Autonomix Medical Common, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to validate all of Autonomix Medical Common prevailing market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. | Last Reported | Projected for Next Year | ||
| Net Loss | -10.3 M | -10.8 M | |
| Net Loss | -10.3 M | -10.8 M | |
| Net Loss | (7.43) | (7.80) |
Autonomix | Net Income | Build AI portfolio with Autonomix Stock |
Latest Autonomix Medical's Net Income Growth Pattern
Below is the plot of the Net Income of Autonomix Medical Common over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Autonomix Medical Common financial statement analysis. It represents the amount of money remaining after all of Autonomix Medical Common operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Autonomix Medical's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Autonomix Medical's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (11.41 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Autonomix Net Income Regression Statistics
| Arithmetic Mean | (12,342,472) | |
| Coefficient Of Variation | (23.62) | |
| Mean Deviation | 1,755,111 | |
| Median | (13,328,715) | |
| Standard Deviation | 2,915,008 | |
| Sample Variance | 8.5T | |
| Range | 13.4M | |
| R-Value | 0.37 | |
| Mean Square Error | 7.8T | |
| R-Squared | 0.14 | |
| Significance | 0.14 | |
| Slope | 216,100 | |
| Total Sum of Squares | 136T |
Autonomix Net Income History
Other Fundumenentals of Autonomix Medical Common
Autonomix Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Autonomix Medical is extremely important. It helps to project a fair market value of Autonomix Stock properly, considering its historical fundamentals such as Net Income. Since Autonomix Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Autonomix Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Autonomix Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Autonomix Medical. If investors know Autonomix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Autonomix Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Autonomix Medical Common is measured differently than its book value, which is the value of Autonomix that is recorded on the company's balance sheet. Investors also form their own opinion of Autonomix Medical's value that differs from its market value or its book value, called intrinsic value, which is Autonomix Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Autonomix Medical's market value can be influenced by many factors that don't directly affect Autonomix Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Autonomix Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Autonomix Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Autonomix Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Autonomix Medical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Autonomix Medical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Autonomix Medical.
| 10/28/2025 |
| 01/26/2026 |
If you would invest 0.00 in Autonomix Medical on October 28, 2025 and sell it all today you would earn a total of 0.00 from holding Autonomix Medical Common or generate 0.0% return on investment in Autonomix Medical over 90 days. Autonomix Medical is related to or competes with Movano, Flora Growth, Kala Pharmaceuticals, Venus Concept, Oragenics, Heart Test, and Bone Biologics. Autonomix Medical is entity of United States More
Autonomix Medical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Autonomix Medical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Autonomix Medical Common upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 74.93 | |||
| Value At Risk | (11.93) | |||
| Potential Upside | 7.5 |
Autonomix Medical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Autonomix Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Autonomix Medical's standard deviation. In reality, there are many statistical measures that can use Autonomix Medical historical prices to predict the future Autonomix Medical's volatility.| Risk Adjusted Performance | (0.07) | |||
| Jensen Alpha | (0.95) | |||
| Total Risk Alpha | (1.84) | |||
| Treynor Ratio | 2.19 |
Autonomix Medical January 26, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.07) | |||
| Market Risk Adjusted Performance | 2.2 | |||
| Mean Deviation | 5.06 | |||
| Coefficient Of Variation | (941.29) | |||
| Standard Deviation | 9.15 | |||
| Variance | 83.66 | |||
| Information Ratio | (0.11) | |||
| Jensen Alpha | (0.95) | |||
| Total Risk Alpha | (1.84) | |||
| Treynor Ratio | 2.19 | |||
| Maximum Drawdown | 74.93 | |||
| Value At Risk | (11.93) | |||
| Potential Upside | 7.5 | |||
| Skewness | 3.98 | |||
| Kurtosis | 25.63 |
Autonomix Medical Common Backtested Returns
Autonomix Medical Common secures Sharpe Ratio (or Efficiency) of -0.11, which signifies that the company had a -0.11 % return per unit of risk over the last 3 months. Autonomix Medical Common exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Autonomix Medical's Mean Deviation of 5.06, standard deviation of 9.15, and Risk Adjusted Performance of (0.07) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.45, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Autonomix Medical are expected to decrease at a much lower rate. During the bear market, Autonomix Medical is likely to outperform the market. At this point, Autonomix Medical Common has a negative expected return of -0.99%. Please make sure to confirm Autonomix Medical's treynor ratio, accumulation distribution, as well as the relationship between the Accumulation Distribution and price action indicator , to decide if Autonomix Medical Common performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.24 |
Weak predictability
Autonomix Medical Common has weak predictability. Overlapping area represents the amount of predictability between Autonomix Medical time series from 28th of October 2025 to 12th of December 2025 and 12th of December 2025 to 26th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Autonomix Medical Common price movement. The serial correlation of 0.24 indicates that over 24.0% of current Autonomix Medical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.24 | |
| Spearman Rank Test | 0.07 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Autonomix Operating Income
Operating Income |
|
Based on the recorded statements, Autonomix Medical Common reported net income of (11.41 Million). This is 103.34% lower than that of the Health Care Equipment & Supplies sector and 104.79% lower than that of the Health Care industry. The net income for all United States stocks is 102.0% higher than that of the company.
Autonomix Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Autonomix Medical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Autonomix Medical could also be used in its relative valuation, which is a method of valuing Autonomix Medical by comparing valuation metrics of similar companies.Autonomix Medical is currently under evaluation in net income category among its peers.
Autonomix Fundamentals
| Return On Equity | -3.52 | ||||
| Return On Asset | -1.59 | ||||
| Current Valuation | (7.47 M) | ||||
| Shares Outstanding | 6.91 M | ||||
| Shares Owned By Insiders | 6.71 % | ||||
| Shares Owned By Institutions | 4.77 % | ||||
| Number Of Shares Shorted | 1.54 M | ||||
| Price To Book | 0.50 X | ||||
| EBITDA | (11.05 M) | ||||
| Net Income | (11.41 M) | ||||
| Total Debt | 1.71 M | ||||
| Book Value Per Share | 1.04 X | ||||
| Cash Flow From Operations | (8.26 M) | ||||
| Short Ratio | 0.23 X | ||||
| Earnings Per Share | (4.51) X | ||||
| Target Price | 6.6 | ||||
| Market Capitalization | 3.22 M | ||||
| Total Asset | 9.81 M | ||||
| Retained Earnings | (50.38 M) | ||||
| Working Capital | 7.9 M | ||||
| Net Asset | 9.81 M |
About Autonomix Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Autonomix Medical Common's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Autonomix Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Autonomix Medical Common based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Autonomix Stock Analysis
When running Autonomix Medical's price analysis, check to measure Autonomix Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Autonomix Medical is operating at the current time. Most of Autonomix Medical's value examination focuses on studying past and present price action to predict the probability of Autonomix Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Autonomix Medical's price. Additionally, you may evaluate how the addition of Autonomix Medical to your portfolios can decrease your overall portfolio volatility.